Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_assertion type Assertion NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_head.
- NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_assertion description "[Our study used in situ hybridization to quantify 5-HT(1A), 5-HT(1B), and 5-HT(2A) mRNA levels in the hippocampus (HC) and 5-HT(1A) and 5-HT(2A) mRNA levels in the dorsolateral prefrontal cortex (DLPFC) of subjects with a history of major depression disorder (MDD), bipolar disorder (BPD), schizophrenia, and a normal comparison group (15 subjects per group).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_provenance.
- NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_assertion evidence source_evidence_literature NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_provenance.
- NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_assertion SIO_000772 14744462 NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_provenance.
- NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_assertion wasDerivedFrom befree-2016 NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_provenance.
- NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_assertion wasGeneratedBy ECO_0000203 NP429522.RAL7R2jf1bD70byiA_VPvqdKrA-UVmqRttARdQzbLNLeg130_provenance.